We served as lead counsel representing a national pharmaceutical ingredient supplier and its wholly owned subsidiaries in a DOJ investigation of alleged FCA violations concerning inflated Average Wholesale Prices, kickbacks to physicians, and waivers of co-pays. After a several-year investigation based on the filing of four separate qui tams, we negotiated a successful resolution of the litigation that was substantially less than the government’s alleged damages.
Representation of National Pharmaceutical Ingredient Supplier: U.S. ex rel. Hueseman v. PSI (W.D. Tex.); U.S. ex rel. Sten v. Midwest Compounders (N.D. Iowa)
Representation of National Pharmaceutical Ingredient Supplier: U.S. ex rel. Hueseman v. PSI (W.D. Tex.); U.S. ex rel. Sten v. Midwest Compounders (N.D. Iowa)
We served as lead counsel representing a national pharmaceutical ingredient supplier and its wholly owned subsidiaries in a DOJ investigation of alleged FCA violations concerning inflated Average Wholesale Prices, kickbacks to physicians, and waivers of co-pays. After a several-year investigation based on the filing of four separate qui tams, we negotiated a successful resolution of the litigation that was substantially less than the government’s alleged damages.